Is NATCO Pharma Limited stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, NATCO Pharma Limited pays dividends. Last time was Wednesday 11th of September 2024 where the investors holding the stock on Friday 23rd of August 2024 were paid INR3 per share. Over the last 36 times between 1996 and 2024, NATCO Pharma Limited has paid INR84 with an average of INR2.33 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for NATCO Pharma Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR583.45, you would have made a profit of INR976.45 per share or 167.36%
Yes, the average daily trading liquidity for NATCO Pharma Limited is INR1.12 million. You should therefore be able to get in and out of your positions relatively fast.
NATCO Pharma Limited has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.93, the company's ability to pay off the debt is good. NATCO Pharma Limited has a very good net profit margin of 34.72% and should have very high tolerances against inflation.
We have calculated the inflation risk for NATCO Pharma Limited to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.